Parnax Lab seeks approval for director re-appointment
Parnax Lab Limited has initiated a postal ballot process to seek shareholder approval for the re-appointment of Mr. Yogesh Kantilal Varia as a Non-Executive Independent Director for a term of five years effective from May 28, 2026. The company has engaged M/s. MUFG Intime India Pvt. Ltd. to facilitate remote e-voting, which commences on July 10, 2026, and concludes on August 8, 2026. Shareholders as on the cut-off date of July 3, 2026, are eligible to participate in the voting process.

*this image is generated using AI for illustrative purposes only.
Parnax Lab Limited has initiated a postal ballot process to seek shareholder approval for the re-appointment of Mr. Yogesh Kantilal Varia as a Non-Executive Independent Director for a term of five years. The resolution, subject to shareholder consent, proposes the appointment effective from May 28, 2026, to May 27, 2031. The Board of Directors approved the proposal during its meeting held on May 28, 2026, based on the recommendation of the Nomination & Remuneration Committee.
Postal Ballot Calendar
The company has established a schedule for the postal ballot and e-voting process. The cut-off date for determining voting rights is July 3, 2026. The remote e-voting facility will be available from July 10, 2026, at 9:00 A.M. (IST) until August 8, 2026, at 5:00 P.M. (IST). The results of the postal ballot are scheduled to be declared on or before August 10, 2026.
| Sr. No. | Particulars | Date |
|---|---|---|
| 1. | Cut-off Date for E-voting Rights | July 03, 2026 |
| 2. | Date of Commencement of E-Voting | July 10, 2026 |
| 3. | Last Date for E-Voting | August 08, 2026 |
| 4. | Date of Declaration of Results | On or before August 10, 2026 |
Director Profile and Disclosures
Mr. Yogesh Kantilal Varia (DIN: 09186184) possesses over 40 years of experience in pharmaceutical and cosmetics manufacturing. He holds a Bachelor of Science (BSE) degree. The company has received his consent to act as a director via Form DIR-2 and a declaration of disqualification via Form DIR-8. He has also submitted a declaration confirming he meets the independence criteria under Section 149(6) of the Companies Act, 2013. Mr. Varia does not hold any shares in the company and is not related to any other directors or key managerial personnel.
Voting Process and Scrutinizer
M/s. MUFG Intime India Pvt. Ltd. has been appointed to provide the e-voting facility. The Board has appointed Mr. Hemant Shetye or Mr. Kunal Sakpal, Designated Partners of HSPN & Associates LLP, as the Scrutinizer to ensure the process is conducted fairly. Shareholders can cast their votes electronically through the InstaVote platform or via their respective depositories, NSDL and CDSL. The notice is available on the company's website and the website of MUFG Intime.
Historical Stock Returns for Parnax Lab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +6.09% | +7.45% | +18.08% | +36.52% | +485.77% |
How will Mr. Varia's extensive pharmaceutical experience influence Parnax Lab's strategic direction over the next five years?
What factors might influence shareholder sentiment regarding the re-appointment of a director who holds no equity in the company?
Could the appointment signal potential shifts in Parnax Lab's corporate governance or board composition?



























